Reprogramming M2b Macrophages via GPX1 Activation by Selenium Nanoparticles Attenuates Lupus Nephritis
Advanced Science · 2026-02 · 13 (12)
DOI: 10.1002/advs.202519981 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 17.12.2025. Verfasst von Haoran Lv und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 518000, China. Hauptthemen laut MEDLINE: Selenium, Lupus Nephritis, Macrophages, Nanoparticles. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Guangdong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
Lupus nephritis (LN), a severe complication of systemic lupus erythematosus (SLE), is largely driven by dysregulated macrophage responses. However, the heterogeneity of macrophages hinders the development of targeted therapies for LN. Here, through single‐cell analysis and clinical specimen validation, it is found that pro‐inflammatory M2b macrophages are increased in the kidneys of patients with LN and are strongly associated with clinical indicators. To target and modulate M2b macrophages, mannose‐functionalized selenium nanoparticles are engineered that can selectively suppress M2b polarization and activation by reducing reactive oxygen species (ROS), restoring mitochondrial function, and inducing selenoprotein glutathione peroxidase 1 (GPX1). In vivo, SeZM NPs accumulate in the kidneys of lupus mice and reduce M2b‐derived pro‐inflammatory cytokines, preserving renal structure and function. Together, these findings highlight pro‐inflammatory M2b macrophages as pathogenic drivers of LN and demonstrate the translational potential of selenium‐based nanotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 518000, China.
- NHC Key Laboratory of Clinical Nephrology (Sun Yat-sen University) and Guangdong Provincial Key Laboratory of Nephrology, Sun Yat-sen University, Guangzhou, 518000, China.
- Department of Nephrology, Jieyang People's Hospital, Jieyang, China.
- State Key Laboratory of Bioactive Molecules and Druggability Assessment, MOE Key Laboratory of Tumor Molecular Biology, Department of Chemistry, Jinan University, Guangzhou, China.
- Department of Pathology, The First Affiliated Hospital, Sun Yatsen University, Guangzhou, 518000, China.
- Basic and Translational Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 518000, China.
ORCID-Profile: Qinghua Liu
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Guangdong Basic and Applied Basic Research Foundation
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Lv, H., Huang, G., Li, H., Liang, H., Peng, H., Wu, K., Chen, W., Zhang, D., Ma, K., Du, Y., Luo, S., Zhou, Y., Mao, H., Chen, W., Chen, T., Zhou, Y., & Liu, Q. (2026). Reprogramming M2b Macrophages via GPX1 Activation by Selenium Nanoparticles Attenuates Lupus Nephritis. Advanced Science, 13(12). https://doi.org/10.1002/advs.202519981
Vancouver
Lv H, Huang G, Li H, Liang H, Peng H, Wu K, et al. Reprogramming M2b Macrophages via GPX1 Activation by Selenium Nanoparticles Attenuates Lupus Nephritis. Advanced Science. 2026;13(12). doi:10.1002/advs.202519981
BibTeX
@article{Lv2026,
author = {Lv, Haoran and Huang, Guanning and Li, Hongyu and Liang, Hanzhi and Peng, Huajing and Wu, Kefei and Chen, Wenfang and Zhang, Dandan and Ma, Kexin and Du, Yufei and Luo, Siweier and Zhou, Yi and Mao, Haiping and Chen, Wei and Chen, Tianfeng and Zhou, Yiming and Liu, Qinghua},
title = {Reprogramming M2b Macrophages via GPX1 Activation by Selenium Nanoparticles Attenuates Lupus Nephritis},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {12},
doi = {10.1002/advs.202519981}
}
EUVIMED